Demographic Data |
Relation to Proband |
proband |
Age at Sampling |
48 YR |
Sex |
Female |
Age at Diagnosis(If not a control) |
17 YR |
Racial Category |
White |
Country |
USA |
|
Data Elements |
Clinical Element Type: General NIGMS Catalog Remarks |
(Baseline) |
Mutation Information |
Age of Symptom Onset and Age at Diagnosis |
Age at Diagnosis: |
17 YEARS |
In Utero History Information |
|
|
Birth History Information |
|
|
Additional Information: |
BIRTH WEIGHT OF 6 LBS, 14.5 OZ; POOR WIGHT GAIN AT THE NEWBORN STAGE |
Dysmorphic Features |
|
|
Neurological Symptoms |
|
|
Optical and Audiological Symptoms |
|
Defective hearing
|
Additional Information: |
MODERATE HIGH FREQUENCY HEARING LOSS WITH 100% IN ONE EAR AND 96% IN THE OTHER EAR; ONSET OF HEARING LOSS AT 25 YEARS OF AGE |
Musculoskeletal Symptoms |
|
Scoliosis
|
Additional Information: |
MINIMAL RIGHT SCOLIOSIS |
Developmental Milestones |
|
|
Additional Information: |
SAT AT 9 MONTHS, WALKED AT 14 MONTHS, 2-3 WORD SENTENCES AT 2 YEARS |
Gastrointestinal Symptoms |
|
|
Genitourinary Symptoms |
|
|
Additional Information: |
NASCENT GONADOBLASTOMA |
Respiratory and Cardiovascular Symptoms |
|
|
Cognitive and Behavioral Symptoms |
|
|
Additional Information |
Testing Performed |
Respiratory and Cardiovascular Testing: |
ECHOCARDIOGRAM REVEALED MILD AORTIC VALVE REGURGITATION |
Uncategorized Testing: |
CHROMOSOME STUDIES REVEALED MOSAIC TURNER SYNDROME; NORMAL RENAL ULTRASOUND |
Treatments and Assistive Devices |
|
|
Additional Testing: |
GONADECTOMY TO TREAT GONADOBLASTOMA |
Medications |
|
NORVASC FOR HYPERTENSION; FEMHRT FEMALE HORMONE REPLACEMENT FOR OVARIAN DYSFUNCTION |
Family History |
Remarks |
Researchers purchasing hiPSCs from the NIGMS Repository are responsible for any limited use label licenses (LULLs) applicable to the cell line purchased. The applicable LULL to this line is Sendai-CytoTune. |